Osteoporosis: Effective Prevention and Modern Bone Treatment Methods

Osteoporosis is a chronic, progressive skeletal disease characterized by a decrease in bone density and deterioration of the microarchitecture of bone tissue, leading to increased bone fragility and fracture risk. Often referred to as the "silent epidemic," osteoporosis can develop unnoticed over many years, manifesting only after the first fracture. Understanding risk factors, as well as modern methods of prevention and treatment, is critical for maintaining bone health and improving quality of life.

What is osteoporosis and why is it important?

Osteoporosis causes bones to become porous and weak, much like a sponge, significantly increasing the likelihood of fractures even from minor trauma. These fractures, especially of the hip, vertebrae, and wrist, can lead to chronic pain, disability, and loss of independence. The disease affects millions of people worldwide, and preventing it is a public health priority.

Risk factors: who is in the danger zone?

The development of osteoporosis is driven by multiple factors, some of which are modifiable while others are not. Studies show that bone mineral density (BMD) is influenced by the following aspects:

• **Gender and Age:** Women, especially postmenopausal women, are more susceptible to osteoporosis due to decreased estrogen levels. Age is also a significant factor, as BMD naturally decreases over the years [2].
• **Menopausal Status:** In women, the onset of menopause is one of the key factors affecting BMD [2].
• **Body Mass Index (BMI):** A low BMI may be associated with an increased risk of osteoporosis [2].
• **Bad Habits:** Smoking and alcohol consumption negatively correlate with BMD, increasing the risk of developing the disease [2].
• **Nutrition and Trace Elements:** Nutritional status, in particular iodine levels, influences bone metabolism. The study showed that both BMD and calcium (Ca2+) levels vary significantly across different levels of iodine intake. Furthermore, a negative correlation was found between high urinary and serum iodine concentrations and BMD [2]. This underscores the importance of balanced iodine intake rather than excess.
• **Hormonal Background:** Free thyroxine and thyroid-stimulating hormone (TSH) levels are also associated with BMD [2].
• **Genetics and Chronic Diseases:** In children and adolescents, genetic factors and the presence of chronic diseases can significantly compromise bone growth and mineral accumulation, increasing the lifetime risk of osteoporosis [8].

Osteoporosis prevention: the foundations of healthy bones

Prevention of osteoporosis begins long before the first symptoms appear and includes a comprehensive approach to lifestyle and nutrition.

Nutrition for strong bones

• **Calcium and Iodine:** Maintaining adequate calcium levels is crucial for bone health, as shown in studies where Ca2+ levels were associated with BMD [2]. Regarding iodine, it is important to avoid both deficiency and excess. The study revealed a negative correlation between high iodine concentrations and BMD, indicating the need for a balanced intake of this trace element [2].
• **Balanced Diet:** Although specific diets for osteoporosis prevention were not the primary focus of all presented studies, a balanced diet rich in vitamins and minerals is known to support overall health, including the skeletal system. For example, the Mediterranean diet has been shown to be effective in reducing stroke risk [6], which indirectly indicates its overall health benefits.

Lifestyle and physical activity

• **Regular Exercise:** Physical activity plays a key role in strengthening bones. Studies show that regular exercise can reduce the risk of various diseases [6]. Weight-bearing exercises such as walking, running, dancing, and strength training are especially beneficial for bones as they stimulate bone tissue renewal and strengthening.
• **Giving Up Bad Habits:** Smoking and excessive alcohol consumption are proven risk factors for reduced BMD and should be eliminated from the lifestyle [2].

Special attention to childhood and adolescence

Childhood and adolescence are critical periods for optimizing bone growth and mineral accumulation. Bone strength is determined by its size, geometry, quality, and mass—variables influenced by genetic factors, physical activity, nutrition, and hormones. For children with genetic skeletal disorders or chronic diseases, bone growth and mineral accumulation may be impaired, increasing the future risk of osteoporosis [8]. The goal is to identify children at highest risk for future fractures.

Modern approaches to osteoporosis treatment

In addition to preventive measures, there are pharmacological treatments for osteoporosis aimed at strengthening bone tissue and reducing fracture risk.

• **Sclerostin Inhibition:** One modern therapeutic approach is the pharmacological inhibition of sclerostin (SOST), a protein that suppresses new bone formation. Sclerostin inhibitors are clinically used to treat osteoporosis [4]. However, it is important to note that large-scale randomized controlled trials report conflicting data regarding the cardiovascular effects of SOST inhibition, requiring further study [4].

Osteoporosis in children: features and challenges

Diagnosis and treatment of osteoporosis in children present specific challenges. Interpreting bone densitometry and bone turnover markers in children is difficult, and methods for preventing and treating bone fragility in children are less studied compared to adults [8]. Therefore, it is crucial to timely identify children at risk and apply individualized management approaches.

Sources

• [1] Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial. https://pubmed.ncbi.nlm.nih.gov/36396451/
• [2] Relationships between iodine nutrition status, and bone mineral density and bone metabolism: a cross-sectional study of 1207 thyroid disease-free adults in China. https://pubmed.ncbi.nlm.nih.gov/40207447/
• [3] SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study). https://pubmed.ncbi.nlm.nih.gov/42360082/
• [4] Proxied therapeutic inhibition on sclerostin and atrial fibrillation risk. https://pubmed.ncbi.nlm.nih.gov/42218280/
• [5] Evaluation of the Use of Primary Prevention Aspirin in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant for Stroke Prevention. https://pubmed.ncbi.nlm.nih.gov/41450132/
• [6] Comparative Effects of Non-Pharmacological Interventions for Stroke Prevention in Adults: A Network Meta-Analysis. https://pubmed.ncbi.nlm.nih.gov/41615868/
• [7] Catheter Ablation and Oral Anticoagulation for Secondary Stroke Prevention in Atrial Fibrillation: The STABLED Randomized Clinical Trial. https://pubmed.ncbi.nlm.nih.gov/41770549/
• [8] Consensus and controversy regarding osteoporosis in the pediatric population. https://pubmed.ncbi.nlm.nih.gov/17872354/

The information presented in this article is for reference purposes only and should not be used for self-diagnosis or self-treatment. Always consult a qualified medical professional for an accurate diagnosis and an individualized treatment plan.